Request a Quote

Trading Update

Cyprotex PLC ("Cyprotex" or "the Company" or "the Group")

Cyprotex (LSE:CRX), the drug discovery technology and information company, notes yesterday's fall in the share price and is unaware of any reason for this share price movement. The Company re-iterates that its current trading is in line with market expectations following its trading update of 20 November 2009.

The Company expects to release a trading update towards the end of January 2010, in respect of calendar year ended 31 December 2009.

For further information:

Cyprotex PLC

Dr Anthony Baxter, Chief Executive Officer

John Dootson, Chief Financial Officer

Tel: +44 (0) 1625 505 100

Noble & Company

John Llewellyn-Lloyd

Tel: +44 (0) 20 7763 2200

Financial Dynamics

Ben Brewerton / Ben Atwell / John Dineen

Tel: +44 (0) 20 7831 3113

Contact us


Contact us to discuss your ADME Tox issues or request a quote

Europe: +44 (0)1625 505100
North America (East Coast): +1-888-297-7683

or fill out the form below:


Download file